Y. Miyagi

发表

p53 mutation spectra for squamous cell carcinomas at different levels of human bronchial branches

Y. Ishikawa, K. Nakagawa, E. Tsuchiya, 2006, International journal of cancer.

Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas.

N. Wada, H. Hayashi, Y. Rino, 2007, Anticancer research.

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion

Y. Miyagi, Y. Kameda, T. Ohtsu, 2010, British Journal of Cancer.

Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer

Y. Kameda, Y. Sakuma, F. Oshita, 2006, British Journal of Cancer.

Expression of Membrane Type 1-Matrix Metalloproteinase and CD44 Variant 6 in Superficial Esophageal Squamous Cell Carcinoma

T. Aoki, Y. Koyanagi, T. Ogata, 2003 .

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study

Y. Miyagi, H. Grabsch, T. Yoshikawa, 2013, British Journal of Cancer.

Etiologic value of p53 mutation spectra and differences with histology in lung cancers

Y. Ishikawa, A. Okada, K. Nakagawa, 2008, Cancer science.

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study

H. Grabsch, T. Yoshikawa, G. Meijer, 2014, British Journal of Cancer.

Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.

M. Tsukuda, A. Kubota, Yoshiyasu Nakamura, 2004, Auris, nasus, larynx.

Etiologic value of p53 mutation spectra and differences with histology in lung cancers

Y. Ishikawa, A. Okada, K. Nakagawa, 2008, Cancer science.